The role of plasma exchange on short-term survival in patients with acute-on-chronic liver failure

  • Bùi Hữu Hoàng Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh
  • Võ Huy Văn Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh
  • Bùi Khánh Duy Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh
  • Quách Tiến Phong Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh
  • Phan Thế Sang Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh
  • Nguyễn Thị Thu Hải Bệnh viện Nguyễn Trãi, Thành phố Hồ Chí Minh

Main Article Content

Keywords

Plasma exchange, acute-on-chronic liver failure, short-term survival rate

Abstract

Objective: To evaluate the effectiveness of plasma exchange (PE) on short-term survival in patients with acute-on-chronic liver failure (ACLF). Subject and method: A study describing the series of cases from January 2019 to July 2022, patients admitted to the University Medical Center - Ho Chi Minh City who met diagnostic criteria for ACLF following the criteria of Asian Pacific Association for the Study of the Liver 2019 (APASL) were enrolled. Result: 95 patients (72 patients in the standard medical care (SMC) group and 23 patients in the PE group) met the inclusion criteria. Age, gender, precipitating factors of ACLF, the severity of hepatic encephalopathy, level of albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), sodium, lactate, creatinine, and ammonia were not significantly different between the PE and SMC groups. Compared to patients in the SMC group, patients in the PE group had substantially lower levels of INR, total bilirubin, MELD score, MELD-Na score, and APASL-AARC research consortium (AARC) score. Patients in PE groups also significantly had a higher 30-day survival rate (60.87% vs 36.11%, p=0.036). However, there was no appreciable difference in the 90-day survival rate (39.13% vs. 27.78%, p=0.303). Conclusion: The 30-day survival rate in the PE group was significantly higher, indicating that PE may be an effective treatment in prolonging patient's survival while waiting for a liver transplant.

Article Details

References

1. Jalan R, Williams R (2002) Acute-on-chronic liver failure: Pathophysiological basis of therapeutic options. Blood Purif 20(3): 252-2612.
2. Moreau R, Jalan R, Ginès P et al (2013) Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144(7): 1426-1437.
3. Clària J, Stauber RE, Coenraad MJ et al (2016) Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology 64: 1249-1264.
4. Bernsmeier C, Pop OT, Singanayagam A et al (2015) Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology 148(3): 603-615.
5. Fernández J, Acevedo J, Wiest R et al (2018) Bacterial and fungal infections in acuteon-chronic liver failure: Prevalence, characteristics and impact on prognosis. Gut 67: 1870-1880.
6. Sarin SK, Choudhury A, Sharma MK et al (2019) Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): An update. Hepatol Int 13: 353-390. (APASL 2019).
7. Kribben A, Gerken G, Haag S et al (2012) Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142(4): 782-789.
8. Bañares R, Nevens F, Larsen FS et al (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial. Hepatology 57: 1153-1162.
9. Thompson J, Jones N, Al-Khafaji A et al Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl 24: 380-393.
10. Mao W, Ye B, Lin S, Fu Y, Chen Y, Chen Y (2010) Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment. ASAIO J 56(5): 475-478.
11. Qin G, Shao JG, Wang B, Shen Y, Zheng J, Liu XJ, Zhang YY, Liu YM, Qin Y, Wang LJ (2014) Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: A single-center experience. Medicine (Baltimore) 93(28): 338.
12. Yue-Meng W, Yang LH, Yang JH, Xu Y, Yang J, Song GB (2016) The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure. Hepatol Int 10(3): 462-469.
13. Uchino J, Matsushita M (1994) Strategies for the rescue of patients with liver failure. ASAIO J 40(1): 74-77. PMID: 8186497.